A decade ago, stem or progenitor cells held the promise of tissue regeneration in human
myocardium, with the expectation that these therapies could rescue ischemic myocyte …

Chronic anemia is an independent risk factor for mortality in patients with heart failure (HF).
Restoring physiological hemoglobin (Hb) levels is essential to increase oxygen transport …

Hematopoietic stem cells (HSC) represent the prototype stem cell within the body. Since
their discovery, HSC have been the focus of intensive research, and have proven invaluable …

Heart disease is a major cause of morbidity and mortality. Cellular therapies hold significant
promise for patients with heart disease. Heart-derived progenitor cells are capable of …

Purpose The purpose of this study is to evaluate the therapeutic efficacy and safety of stem
cells for the treatment of patients with ST-segment elevation myocardial infarction (STEMI) …

This review focuses on the current status of research that utilizes the application of
pharmacological sciences to accelerate, optimize and characterize the development …

The contribution of stem cells to cure damaged hearts has finally been unraveled. A large
number of preclinical and clinical studies have showed beneficial outcomes after myocardial …

Myocardial infarction is one of the main cause of mortality in many countries. Therefore, an
effective therapy for myocardial infarction is required. Reperfusion and other conventional …

Introduction: Heart failure due to IHD is one of the most common causes of morbidity in
Indonesia. The promising stem cell therapy for IHD patients has been conducted in …

Penelitian terapi sel punca di dunia telah berkembang dengan pesat dalam beberapa dasa
warsa terakhir, khususnya pada penyakit jantung seperti infark miokard akut, penyakit …